201 related articles for article (PubMed ID: 21738796)
1. Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.
Kammerer R; Buchner A; Palluch P; Pongratz T; Oboukhovskij K; Beyer W; Johansson A; Stepp H; Baumgartner R; Zimmermann W
PLoS One; 2011; 6(6):e21834. PubMed ID: 21738796
[TBL] [Abstract][Full Text] [Related]
2. IL-6 potentiates tumor resistance to photodynamic therapy (PDT).
Brackett CM; Owczarczak B; Ramsey K; Maier PG; Gollnick SO
Lasers Surg Med; 2011 Sep; 43(7):676-85. PubMed ID: 22057495
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response.
Mroz P; Szokalska A; Wu MX; Hamblin MR
PLoS One; 2010 Dec; 5(12):e15194. PubMed ID: 21179470
[TBL] [Abstract][Full Text] [Related]
4. High-field magnetic resonance imaging of the response of human prostate cancer to Pc 4-based photodynamic therapy in an animal model.
Fei B; Wang H; Meyers JD; Feyes DK; Oleinick NL; Duerk JL
Lasers Surg Med; 2007 Oct; 39(9):723-30. PubMed ID: 17960753
[TBL] [Abstract][Full Text] [Related]
5. Effects of LED-Based photodynamic therapy using red and blue lights, with natural hydrophobic photosensitizers on human glioma cell line.
Jamali Z; Hejazi SM; Ebrahimi SM; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Mar; 21():50-54. PubMed ID: 29126958
[TBL] [Abstract][Full Text] [Related]
6. Multilayer photodynamic therapy for highly effective and safe cancer treatment.
Yang L; Zhang S; Ling X; Shao P; Jia N; Bai M
Acta Biomater; 2017 May; 54():271-280. PubMed ID: 28285077
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy and anti-tumor immunity.
Gollnick SO; Owczarczak B; Maier P
Lasers Surg Med; 2006 Jun; 38(5):509-15. PubMed ID: 16788921
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the in vitro and in vivo effects of photodynamic therapy on prostate cancer by using new photosensitizers, protoporphyrin IX-polyamine derivatives.
Fidanzi-Dugas C; Liagre B; Chemin G; Perraud A; Carrion C; Couquet CY; Granet R; Sol V; Léger DY
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1676-1690. PubMed ID: 28188858
[TBL] [Abstract][Full Text] [Related]
9. Near-infrared light-activated red-emitting upconverting nanoplatform for T
Tang XL; Wu J; Lin BL; Cui S; Liu HM; Yu RT; Shen XD; Wang TW; Xia W
Acta Biomater; 2018 Jul; 74():360-373. PubMed ID: 29763715
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
Wei LH; Baumann H; Tracy E; Wang Y; Hutson A; Rose-John S; Henderson BW
Br J Cancer; 2007 Dec; 97(11):1513-22. PubMed ID: 17987036
[TBL] [Abstract][Full Text] [Related]
11. Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer.
Yamamoto S; Fukuhara H; Seki H; Kawada C; Nakayama T; Karashima T; Ogura SI; Inoue K
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102452. PubMed ID: 34303032
[TBL] [Abstract][Full Text] [Related]
12. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
You Y; Liang X; Yin T; Chen M; Qiu C; Gao C; Wang X; Mao Y; Qu E; Dai Z; Zheng R
Theranostics; 2018; 8(6):1665-1677. PubMed ID: 29556348
[TBL] [Abstract][Full Text] [Related]
13. Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors.
Kleinovink JW; van Driel PB; Snoeks TJ; Prokopi N; Fransen MF; Cruz LJ; Mezzanotte L; Chan A; Löwik CW; Ossendorp F
Clin Cancer Res; 2016 Mar; 22(6):1459-68. PubMed ID: 26546617
[TBL] [Abstract][Full Text] [Related]
14. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
Wang H; Lathia JD; Wu Q; Wang J; Li Z; Heddleston JM; Eyler CE; Elderbroom J; Gallagher J; Schuschu J; MacSwords J; Cao Y; McLendon RE; Wang XF; Hjelmeland AB; Rich JN
Stem Cells; 2009 Oct; 27(10):2393-404. PubMed ID: 19658188
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy boosts anti-glioma immunity in mice: a dependence on the activities of T cells and complement C3.
Li F; Cheng Y; Lu J; Hu R; Wan Q; Feng H
J Cell Biochem; 2011 Oct; 112(10):3035-43. PubMed ID: 21678475
[TBL] [Abstract][Full Text] [Related]
16. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
[TBL] [Abstract][Full Text] [Related]
17. Choline PET for monitoring early tumor response to photodynamic therapy.
Fei B; Wang H; Wu C; Chiu SM
J Nucl Med; 2010 Jan; 51(1):130-8. PubMed ID: 20008981
[TBL] [Abstract][Full Text] [Related]
18. Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.
Weijer R; Broekgaarden M; van Golen RF; Bulle E; Nieuwenhuis E; Jongejan A; Moerland PD; van Kampen AH; van Gulik TM; Heger M
BMC Cancer; 2015 Dec; 15():1014. PubMed ID: 26705830
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin prompts amplification of photodynamic therapy-induced reactive oxygen species to exhaust Na/H exchanger 1-mediated glioma cells invasion and migration.
Hou K; Liu J; Du J; Mi S; Ma S; Ba Y; Ji H; Li B; Hu S
J Photochem Photobiol B; 2021 Jun; 219():112192. PubMed ID: 34000476
[TBL] [Abstract][Full Text] [Related]
20. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth.
deCarvalho AC; Zhang X; Roberts C; Jiang F; Kalkanis SN; Hong X; Lu M; Chopp M
Glia; 2007 Aug; 55(10):1053-60. PubMed ID: 17551928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
